Parkinson's disease (PD) is a neurodegenerative disorder characterized by the selective degeneration of dopaminergic (DA) neurons in the substantia nigra of the midbrain. Pharmacological treatment of PD has been a prevailing strategy. However, it has some limitations because its effectiveness gradually decreases and side effects develop. As an alternative, cell transplantation therapy has been tried. Although transplantation of fetal ventral mesencephalic cells looks promising for the treatment of PD in some cases, ethical and technical problems in obtaining large numbers of human fetal brain tissues also lead to difficulty in its clinical application. Our recent studies showed that a high yield of DA neurons could be derived from embryonic stem (ES) cells and they efficiently induced behavioral recovery in a PD animal model. Here we summarize methods for generation of functional DA neurons from ES cells for application to PD models.
BarberiT.; KlivenyiP.; CalingasanN. Y.; LeeH.; KawamataH.; LoonamK.; PerrierA. L.; BrusesJ.; RubioM. E.; TopfN.; TabarV.; HarrisonN. L.; BealM. F.; MooreM. A.; StuderL.Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice.Nat. Biotechnol.21: 1200-1207; 2003.
4.
Ben-HurT.; IdelsonM.; KhanerH.; PeraM.; ReinhartzE.; ItzikA.; ReubinoffB. E.Transplantation of human embryonic stem cell-derived neural progenitors improves behavioral deficit in parkinsonian rats.Stem Cells22: 1246-1255; 2004.
5.
BjörklundA.; LindvallO.Cell replacement therapies for central nervous system disorders.Nat. Neurosci.3: 537-544; 2000.
6.
BjörklundL. M.; Sanchez-PernauteR.; ChungS.; AnderssonT.; ChenI. Y.; McNaughtK. S.; BrownellA. L.; JenkinsB. G.; WahlestedtC.; KimK. S.; IsacsonO.Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model.Proc. Natl. Acad. Sci. USA99: 2344-2349; 2002.
7.
Buytaert-HoefenK. A.; AlvarezE.; FreedC. R.Generation of tyrosine hydroxylase positive neurons from human embryonic stem cells after coculture with cellular substrates and exposure to GDNF.Stem Cells22: 669-674; 2004.
8.
CastilhoR. F.; HanssonO.; BrundinP.Improving the survival of grafted embryonic dopamine neurons in rodent models of Parkinson's disease.Prog. Brain Res.127: 203-231; 2000.
9.
ChoY. H.; KimD. S.; KimP. G.; HwangY. S.; ChoM. S.; MoonS. Y.; KimD. W.; ChangJ. W.High yield of dopamine neurons from embryonic stem cells efficiently induces behavioral recovery in a parkinsonian rat model.Biochem. Biophys. Res. Commun.340: 1290-1296; 2006.
ChungS.; SonntagK. C.; AnderssonT.; BjörklundL. M.; ParkJ. J.; KimD. W.; KangU. J.; IsacsonO.; KimK. S.Genetic engineering of mouse embryonic stem cells by Nurr1 enhances differentiation and maturation into dopaminergic neurons.Eur. J. Neurosci.16: 1829-1838; 2002.
12.
CoucouvanisE.; MartinG. R.BMP signaling plays a role in visceral endoderm differentiation and cavitation in the early mouse embryo.Development126: 535-546; 1999.
13.
DamierP.New aspects in the pathophysiology of dyskinesia. Salpetriere Deep Brain Stimulation Group.Adv. Neurol.80: 611-617; 1999.
14.
DauerW.; PrzedborskiS.Parkinson's disease: Mechanisms and models.Neuron39: 889-909; 2003.
15.
DowningG. J.; BatteyJ. F.Jr.Technical assessment of the first 20 years of research using mouse embryonic stem cell lines.Stem Cells22: 1168-1180; 2004.
16.
DuZ. W.; ZhangS. C.Neural differentiation from embryonic stem cells: Which way?Stem Cells Dev.13: 372-381; 2004.
17.
DuanW. M.; RodriguesC. M.; ZhaoL. R.; SteerC. J.; LowW. C.Tauroursodeoxycholic acid improves the survival and function of nigral transplants in a rat model of Parkinson's disease.Cell Transplant.11: 195-205; 2002.
18.
EmgardM.; HallinU.; KarlssonJ.; BahrB. A.; BrundinP.; BlomgrenK.Both apoptosis and necrosis occur early after intracerebral grafting of ventral mesencephalic tissue: A role for protease activation.J. Neurochem.86: 1223-1232; 2003.
19.
EvansM. J.; KaufmanM. H.Establishment in culture of pluripotential cells from mouse embryos.Nature292: 154-156; 1981.
20.
FreedC. R.; GreeneP. E.; BreezeR. E.; TsaiW. Y.; DuMouchelW.; KaoR.; DillonS.; WinfieldH.; CulverS.; TrojanowskiJ. Q.; EidelbergD.; FahnS.Transplantation of embryonic dopamine neurons for severe Parkinson's disease.N. Engl. J. Med.344: 710-719; 2001.
21.
GinisI.; LuoY.; MiuraT.; ThiesS.; BrandenbergerR.; Gerecht-NirS.; AmitM.; HokeA.; CarpenterM. K.; Itskovitz-EldorJ.; RaoM. S.Differences between human and mouse embryonic stem cells.Dev. Biol.269: 360-380; 2004.
22.
GratschT. E.; O'SheaK. S.Noggin and chordin have distinct activities in promoting lineage commitment of mouse embryonic stem (ES) cells.Dev. Biol.245: 83-94; 2002.
23.
HeltC. E.; HoernigG. R.; AlbeckD. S.; GerhardtG. A.; IckesB.; ReylandM. E.; QuissellD. O.; StrombergI.; GranholmA. C.Neuroprotection of grafted neurons with a GDNF/caspase inhibitor cocktail.Exp. Neurol.170: 258-269; 2001.
24.
HurelbrinkC. B.; ArmstrongR. J.; LuheshiL. M.; DunnettS. B.; RosserA. E.; BarkerR. A.Death of dopaminergic neurons in vitro and in nigral grafts: Reevaluating the role of caspase activation.Exp. Neurol.171: 46-58; 2001.
25.
JennerP.; SchapiraA. H.; MarsdenC. D.New insights into the cause of Parkinson's disease.Neurology42: 2241-2250; 1992.
26.
KawasakiH.; MizusekiK.; NishikawaS.; KanekoS.; KuwanaY.; NakanishiS.; NishikawaS. I.; SasaiY.Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity.Neuron28: 31-40; 2000.
27.
KawasakiH.; SuemoriH.; MizusekiK.; WatanabeK.; UranoF.; IchinoseH.; HarutaM.; TakahashiM.; YoshikawaK.; NishikawaS.; NakatsujiN.; SasaiY.Generation of dopaminergic neurons and pigmented epithelia from primate ES cells by stromal cell-derived inducing activity.Proc. Natl. Acad. Sci. USA99: 1580-1585; 2002.
KimJ. H.; AuerbachJ. M.; Rodriguez-GomezJ. A.; VelascoI.; GavinD.; LumelskyN.; LeeS. H.; NguyenJ.; Sanchez-PernauteR.; BankiewiczK.; McKayR.Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease.Nature418: 50-56; 2002.
30.
LeahyA.; XiongJ. W.; KuhnertF.; StuhlmannH.Use of developmental marker genes to define temporal and spatial patterns of differentiation during embryoid body formation.J. Exp. Zool.284: 67-81; 1999.
31.
LeeS. H.; LumelskyN.; StuderL.; AuerbachJ. M.; McKayR. D.Efficient generation of midbrain and hind-brain neurons from mouse embryonic stem cells.Nat. Biotechnol.18: 675-679; 2000.
32.
MadenM.Retinoid signaling in the development of the central nerve system.Nat. Rev. Neurosci.3: 843-853; 2002.
33.
MartinatC.; BacciJ. J.; LeeteT.; KimJ.; VantiW. B.; NewmanA. H.; ChaJ. H.; GetherU.; WangH.; AbeliovichA.Cooperative transcription activation by Nurr1 and Pitx3 induces embryonic stem cell maturation to the midbrain dopamine neuron phenotype.Proc. Natl. Acad. Sci. USA103: 2874-2879; 2006.
34.
MaxwellS. L.; LiM.Midbrain dopaminergic development in vivo and in vitro from embryonic stem cells.J. Anat.207: 209-218; 2005.
35.
MoonS. Y.; ParkY. B.; KimD. S.; OhS. K.; KimD. W.Generation, culture, and differentiation of human embryonic stem cells for therapeutic applications.Mol. Ther.13: 5-14; 2005.
36.
Munoz-SanjuanI.; BrivanlouA. H.Neural induction, the default model and embryonic stem cells.Nat. Rev. Neurosci.3: 271-280; 2002.
37.
ObesoJ. A.; Rodriguez-OrozM. C.; RodriguezM.; LanciegoJ. L.; ArtiedaJ.; GonzaloN.; OlanowC. W.Pathophysiology of the basal ganglia in Parkinson's disease.Trends Neurosci.23: 8-19; 2000.
38.
OkabeS.; Forsberg-NilssonK.; SpiroA. C.; SegalM.; McKayR. D.Development of neuronal precursor cells and functional postmitotic neurons from embryonic stem cells in vitro.Mech. Dev.59: 89-102; 1996.
39.
OlanowC. W.; GoetzC. G.; KordowerJ. H.; StoesslA. J.; SossiV.; BrinM. F.; ShannonK. M.; NauertG. M.; PerlD. P.; GodboldJ.; FreemanT. B.A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease.Ann. Neurol.54: 403-414; 2003.
40.
ParkC. H.; MinnY. K.; LeeJ. Y.; ChoiD. H.; ChangM. Y.; ShimJ. W.; KoJ. Y.; KohH. C.; KangM. J.; KangJ. S.; RhieD. J.; LeeY. S.; SonH.; MoonS. Y.; KimK. S.; LeeS. H.In vitro and in vivo analyses of human embryonic stem cell-derived dopamine neurons.J. Neurochem.92: 1265-1276; 2005.
41.
PanchisionD. M.; McKayR. D.The control of neural stem cells by morphogenic signals.Curr. Opin. Genet. Dev.12: 478-487; 2002.
42.
PeraM. F.; AndradeJ.; HoussamiS.; ReubinoffB.; TrounsonA.; StanleyE. G.; Ward-van OostwaardD.; MummeryC.Regulation of human embryonic stem cell differentiation by BMP-2 and its antagonist noggin.J. Cell Sci.117: 1269-1280; 2004.
43.
PerrierA. L.; TabarV.; BarberiT.; RubioM. E.; BrusesJ.; TopfN.; HarrisonN. L.; StuderL.Derivation of midbrain dopamine neurons from human embryonic stem cells.Proc. Natl. Acad. Sci. USA101: 12543-12548; 2004.
44.
Sánchez-PernauteR.; StuderL.; FerrariD.; PerrierA.; LeeH.; ViñuelaA.; IsacsonO.Long-term survival of dopamine neurons derived from parthenogenetic primate embryonic stem cells (cyno-1) after transplantation.Stem Cells23: 914-922; 2005.
45.
Saucedo-CardenasO.; Quintana-HauJ. D.; LeW. D.; SmidtM. P.; CoxJ. J.; De MayoF.; BurbachJ. P.; ConneelyO. M.Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons.Proc. Natl. Acad. Sci. USA95: 4013-4018; 1998.
46.
SchulzT. C.; NoggleS. A.; PalmariniG. M.; WeilerD. A.; LyonsI. G.; PensaK. A.; MeedeniyaA. C.; DavidsonB. P.; LambertN. A.; CondieB. G.Differentiation of human embryonic stem cells to dopaminergic neurons in serum-free suspension culture.Stem Cells22: 1218-1238; 2004.
TropepeV.; HitoshiS.; SirardC.; MakT. W.; RossantJ.; van der KooyD.Direct neural fate specification from embryonic stem cells: A primitive mammalian neural stem cell stage acquired through a default mechanism.Neuron30: 65-78; 2001.
YanY.; YangD.; ZarnowskaE. D.; DuZ.; WerbelB.; ValliereC.; PearceR. A.; ThomsonJ. A.; ZhangS. C.Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells.Stem Cells23: 781-790; 2005.
54.
YeW.; ShimamuraK.; RubensteinJ. L.; HynesM. A.; RosenthalA.FGF and Shh signals control dopaminergic and serotonergic cell fate in the anterior neural plate.Cell93: 755-766; 1998.
55.
YingQ. L.; StavridisM.; GriffithsD.; LiM.; SmithA.Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture.Nat. Biotechnol.21: 183-186; 2003.
56.
YingQ. L.; SmithA. G.Defined conditions for neural commitment and differentiation.Method Enzymol.365: 327-341; 2003.
